Aptinyx Inc.
DelistedCIK 1674365fmd_0PCZXBY0DKJ2HD3NSM8KKHEEZSManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Mar 31, 2023, 24 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Total revenues | 5 | 7 | 4 | 2 | 1 | – |
| Research and development | 32 | 49 | 44 | 33 | 55 | 43 |
| Total operating expenses | 37 | 61 | 63 | 52 | 76 | 63 |
| Operating income | (32) | (55) | (60) | (51) | (75) | (63) |
| Interest expense | – | – | – | – | 1 | 3 |
| Other non-operating income (expense) | 0 | 2 | 2 | 1 | 0 | 1 |
| Income tax expense | – | 0 | 0 | 0 | 0 | 0 |
| Net income | (32) | (53) | (57) | (50) | (75) | (65) |
| Net income to common shareholders | (32) | (53) | (57) | (50) | (75) | (65) |